These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19183154)

  • 21. Predictors of corticosteroid-dependent and corticosteroid-refractory inflammatory bowel disease: analysis of a Chinese cohort study.
    Chow DK; Sung JJ; Tsoi KK; Wong VW; Wu JC; Leong RW; Chan FK
    Aliment Pharmacol Ther; 2009 Apr; 29(8):843-54. PubMed ID: 19154567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical trial: randomized-controlled clinical study comparing the efficacy and safety of a low-volume vs. a high-volume mesalazine foam in active distal ulcerative colitis.
    Eliakim R; Tulassay Z; Kupcinskas L; Adamonis K; Pokrotnieks J; Bar-Meir S; Lavy A; Mueller R; Greinwald R; Chermesh I; Gross V;
    Aliment Pharmacol Ther; 2007 Nov; 26(9):1237-49. PubMed ID: 17944738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The extent and determinants of prescribing and adherence with acid-reducing medications: a national claims database study.
    El-Serag HB; Fitzgerald S; Richardson P
    Am J Gastroenterol; 2009 Sep; 104(9):2161-7. PubMed ID: 19568229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Twelve-month persistency with oral 5-aminosalicylic acid therapy for ulcerative colitis: results from a large pharmacy prescriptions database.
    Kane SV; Sumner M; Solomon D; Jenkins M
    Dig Dis Sci; 2011 Dec; 56(12):3463-70. PubMed ID: 21879279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meta-analysis: the efficacy of rectal beclomethasone dipropionate vs. 5-aminosalicylic acid in mild to moderate distal ulcerative colitis.
    Manguso F; Balzano A
    Aliment Pharmacol Ther; 2007 Jul; 26(1):21-9. PubMed ID: 17555418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of the Medication Persistence Rate for and Adherence to Oral 5-Aminosalicylic Acid Preparations in Japanese Patients with Ulcerative Colitis: Study Using a Nationwide Claims Database.
    Ota T; Takebe T; Shimizu Y; Orido T; Tanaka H; Nakamura S
    Digestion; 2024; 105(3):232-242. PubMed ID: 38527451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Difficulties in taking aminosalicylates for patients with ulcerative colitis.
    Kawakami A; Tanaka M; Ochiai R; Naganuma M; Iwao Y; Hibi T; Kazuma K
    Gastroenterol Nurs; 2012; 35(1):24-31. PubMed ID: 22306727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glaucoma medication persistence with a fixed combination versus multiple bottles.
    Higginbotham EJ; Hansen J; Davis EJ; Walt JG; Guckian A
    Curr Med Res Opin; 2009 Oct; 25(10):2543-7. PubMed ID: 19731993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive factors associated with immunosuppressive agent use in ulcerative colitis: a case-control study.
    Lau A; Chande N; Ponich T; Gregor JC
    Aliment Pharmacol Ther; 2008 Sep; 28(5):606-13. PubMed ID: 18564323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of a screening tool to determine nonadherent behavior in inflammatory bowel disease.
    Kane S; Becker B; Harmsen WS; Kurian A; Morisky DE; Zinsmeister AR
    Am J Gastroenterol; 2012 Feb; 107(2):154-60. PubMed ID: 22306937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A two-stage decision analysis to assess the cost of 5-aminosalicylic acid failure and the economics of balsalazide versus mesalamine in the treatment of ulcerative colitis.
    Mackowiak JI
    Manag Care Interface; 2006 Oct; 19(10):39-46, 56. PubMed ID: 17117598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel 5-aminosalicylic acid formulations in ulcerative colitis: old dog, new tricks.
    Wilson J
    Gastroenterol Nurs; 2008; 31(4):286-92. PubMed ID: 18708833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mesalamine once daily is more effective than twice daily in patients with quiescent ulcerative colitis.
    Dignass AU; Bokemeyer B; Adamek H; Mross M; Vinter-Jensen L; Börner N; Silvennoinen J; Tan G; Pool MO; Stijnen T; Dietel P; Klugmann T; Vermeire S; Bhatt A; Veerman H
    Clin Gastroenterol Hepatol; 2009 Jul; 7(7):762-9. PubMed ID: 19375519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of a tailored patient preference intervention in adherence to 5-aminosalicylic acid medication in ulcerative colitis: results from an exploratory randomized controlled trial.
    Moshkovska T; Stone MA; Smith RM; Bankart J; Baker R; Mayberry JF
    Inflamm Bowel Dis; 2011 Sep; 17(9):1874-81. PubMed ID: 21830265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medication adherence and persistence in the treatment of Canadian ulcerative colitis patients: analyses with the RAMQ database.
    Lachaine J; Yen L; Beauchemin C; Hodgkins P
    BMC Gastroenterol; 2013 Jan; 13():23. PubMed ID: 23363459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Socio-demographic factors influence chronic proton pump inhibitor use by a large population in the Netherlands.
    van Boxel OS; Hagenaars MP; Smout AJ; Siersema PD
    Aliment Pharmacol Ther; 2009 Mar; 29(5):571-9. PubMed ID: 19035978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Granulocytapheresis versus methylprednisolone in patients with acute ulcerative colitis: 12-month follow up.
    Bresci G; Parisi G; Mazzoni A; Scatena F; Capria A
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1678-82. PubMed ID: 18823440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review article: 5-aminosalicylate formulations for the treatment of ulcerative colitis--methods of comparing release rates and delivery of 5-aminosalicylate to the colonic mucosa.
    Lichtenstein GR; Kamm MA
    Aliment Pharmacol Ther; 2008 Sep; 28(6):663-73. PubMed ID: 18532992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term persistence with statin therapy: a nationwide register study in Finland.
    Helin-Salmivaara A; Lavikainen P; Korhonen MJ; Halava H; Junnila SY; Kettunen R; Neuvonen PJ; Martikainen JE; Ruokoniemi P; Saastamoinen LK; Virta L; Huupponen R
    Clin Ther; 2008; 30 Pt 2():2228-40. PubMed ID: 19281917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ulcerative proctitis: a review of pharmacotherapy and management.
    Lakatos PL; Lakatos L
    Expert Opin Pharmacother; 2008 Apr; 9(5):741-9. PubMed ID: 18345952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.